Image 5_A CD1c lipid agnostic T cell receptor bispecific engager redirects T cells against CD1c+ cells.jpeg

Image 5_A CD1c lipid agnostic T cell receptor bispecific engager redirects T cells against CD1c+ cells.jpeg

Introduction<p>Immunotherapy is emerging as an efficacious treatment for some cancers, complementing traditional chemo-radiation therapies. Specific markers at the cell surface of cancer cells can be used as immunotherapy targets. However, many of these markers are defined by a patient’s genet...

Full description

Saved in:
Bibliographic Details
Main Author: Rita Szoke-Kovacs (19467070) (author)
Other Authors: Sophie Khakoo (18207221) (author), Victor Lopes Rangel (21775937) (author), Pietro Della Cristina (21775940) (author), Johanne Pentier (21775943) (author), Rahul Khanolkar (3549323) (author), Sam El-Ajouz (7598525) (author), Robert Simmons (2124061) (author), David K. Cole (8502924) (author), Peter Gogolak (279821) (author), Mariolina Salio (70402) (author), Vijaykumar Karuppiah (4380190) (author)
Published: 2025
Subjects:
Genetic Immunology
T cell receptor
bispecifics
T cell engager
CD1c
lipids
leukemia
immunotherapy
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items